Cargando…
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway
The CXCR4 receptor (Chemokine C-X-C motif receptor 4) is highly expressed in different hematological malignancies including chronic lymphocytic leukemia (CLL). The CXCR4 ligand (CXCL12) stimulates CXCR4 promoting cell survival and proliferation, and may contribute to the tropism of leukemia cells to...
Autores principales: | Kashyap, Manoj K., Kumar, Deepak, Jones, Harrison, Amaya-Chanaga, Carlos I., Choi, Michael Y., Melo-Cardenas, Johanna, Ale-Ali, Amine, Kuhne, Michelle R., Sabbatini, Peter, Cohen, Lewis J., Shelat, Suresh G., Rassenti, Laura Z., Kipps, Thomas J., Cardarelli, Pina M., Castro, Januario E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823073/ https://www.ncbi.nlm.nih.gov/pubmed/26646452 http://dx.doi.org/10.18632/oncotarget.6465 |
Ejemplares similares
-
CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338
por: Pollino, Serena, et al.
Publicado: (2019) -
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
por: Kashyap, Manoj K., et al.
Publicado: (2017) -
Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012) -
1338. Analysis of Prescription Guideline Adherence in Pediatric Outpatient Pneumonia Treatment
por: Heck, Carly, et al.
Publicado: (2020) -
1338. Development of a Novel Application for Differential Diagnosis of Tick-borne Diseases
por: Meyer, Corey, et al.
Publicado: (2019)